Research
Search
Close
YANG Qingcheng
- Chief Physician, Doctoral Supervisor
- Department: Orthopedics
- Research Area: Surgery (Orthopedics)
- Research Interests: Pathogenesis of bone and soft tissue tumors
- Contact: tjyqc@163.com
- Doctoral Degree from Shanghai Jiao Tong University, 2007
- Master’s Degree from Tongji University, 2000
- Bachelor’s Degree from Weifang Medical University, 1990
- Deputy Director, Department of Orthopedics, Shanghai Sixth People's Hospital
- Deputy Director, Traumatic Orthopedics Clinical Medical Center of Shanghai Sixth People's Hospital
- Zhou Y, Yang Q, Dong Y, Ji T, Zhang B, Yang C, Zheng S, Tang L, Zhou C, Qian G, Huang Y, Yu W, Li H, Wang Y, He A, Shen Z, Bao Q, Hua Y, Bai H, Zhao J, Li X, Dai X, Zhang J, Hu H, Yao Y. First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001. Clin Cancer Res. 2023 Feb 16;29(4):764-774. doi: 10.1158/1078-0432.CCR-22-2470.
- Pan Z, Cheng DD, Wei XJ, Li SJ, Guo H, Yang QC. Chitooligosaccharides inhibit tumor progression and induce autophagy through the activation of the p53/mTOR pathway in osteosarcoma. Carbohydr Polym. 2021 Apr 15;258:117596. doi: 10.1016/j.carbpol.2020.117596.
- He Y, Cheng D, Lian C, Liu Y, Luo W, Wang Y, Ma C, Wu Q, Tian P, He D, Jia Z, Lv X, Zhang X, Pan Z, Lu J, Xiao Y, Zhang P, Liang Y, Yang Q, Hu G. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone. Cell Death Dis. 2021 Sep 23;12(10):868. doi: 10.1038/s41419-021-04161-1.
- [Xiaojuan Wei, Dongdong Cheng, Qingcheng Yang, Zhen Pan, Hua Guo, Changqiing Zhang] (2019), “An anticancer composition and its application in the preparation of drugs for the treatment of osteosarcoma”, China, ZL 2019 1 0616302.
